For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260427:nRSa9965Ba&default-theme=true
RNS Number : 9965B Melrose Industries PLC 27 April 2026
27ᵗʰ April 2026
Melrose Industries PLC
("Melrose" or the "Company")
Transaction in Own Shares
The Company announces today it has purchased the following number of its
ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in
the period from 20ᵗʰ April 2026 to 24ᵗʰ April 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (pence) Highest price per share (p)
20 April 2026 XLON 554.6023 56,000 546.8000 557.4000
21 April 2026 XLON 542.5244 57,000 532.4000 559.8000
22 April 2026 XLON 505.5580 60,000 498.1000 522.2000
23 April 2026 XLON 504.6779 64,386 495.7000 512.8000
24 April 2026 XLON 502.6364 63,000 495.1000 506.4000
The Company intends to hold the purchased shares in treasury.
Following the above transaction, the Company has 63,687,214 ordinary shares
in treasury and has 1,247,788,107 ordinary shares in issue (excluding
treasury shares).
Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No
596/2014 as it forms part of UK law, a full breakdown of the individual trades
made by the MLI on behalf of the Company as part of the buyback programme is
attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/9965B_1-2026-4-26.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/9965B_1-2026-4-26.pdf)
For further information please contact:
Warren Fernandez Company
Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSSELEFMEMSEDL
Copyright 2019 Regulatory News Service, all rights reserved